[1]Gkaliagkousi E, Corrigall V, Becker S, et al. Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension[J]. Eur Heart J, 2009, 30(24): 3048-3054.
[2]李环,焦亚斌. 丹参饮精品中药与普通中药对动脉粥样硬化模型大鼠药理作用的比较[J]. 长春中医药大学, 2014, 30(12): 978-979.
[3]Vigetti D, Genasetti A, Karousou E, et al. Proinflammatory cytokines induce hyaluronan synthesis and monocyte adhesion in human endothelial cells through hyaluronan synthase 2 (HAS2) and the nuclear factor-κB (NF-κB) pathway[J]. J Biol Chem, 2010, 285(32): 24639-24645.
[4]费鲜明, 周永列, 祁金文, 等. 木瓜蛋白酶体外对血小板聚集的抑制作用[J]. 中国临床药理学与治疗学, 2009, 14(8): 906- 911.
[5]蒋雷,费鲜明,苗成霖,等. 木瓜蛋白酶对MPA形成及其诱导的单核细胞活化的影响[J]. 中国临床药理学与治疗学,2015, 20(3):289-292.
[6]刘文彬,褚夫江,吴玉萍, 等. 罗仙子提取物对单核细胞与血管内皮细胞黏附的影响[J].中国临床药理学与治疗学,2014,19(7):752-755.
[7]王佐,吕运成,危当恒,等. 基质细胞衍生因子1α对大鼠血管平滑肌细胞与单核细胞粘附的影响[J]. 中国动脉硬化杂志,2006,9:759-762.
[8]Hansson GK, Hermansson A. The immune system in atherosclerosis[J]. Nat Immunol, 2011, 12(3): 204-212.
[9]Van Gils JM, Zwaginga JJ, Hordijk PL. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases[J]. J Leu Biol, 2009, 85(2): 195-204.
[10]Esch JSA, Jurk K, Knoefel WT, et al. Platelet activation and increased tissue factor expression on monocytes in reperfusion injury following orthotopic liver transplantation[J]. Platelets, 2010, 21(5): 348-359.
[11]Passacquale G, Vamadevan P, Pereira L, et al. Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes[J]. PLoS One,2011, 6(10): e25595.
[12]苏林丘, 陈德伟. 单核细胞趋化蛋白1及其受体 CCR2 与冠心病关系的研究进展[J]. 医学综述,2011,17(16):2411-2414.
[13]Fadini GP, Simoni F, Cappellari R, et al. Pro-inflammatory monocyte-macrophage polarization imbalance in human hypercholesterolemia and atherosclerosis[J]. Atherosclerosis, 2014, 237 (2): 805-808.
[14]Duo CC, Gong FY, He XY, et al. Soluble calreticulin induces tumor necrosis factor-α (TNF-α) and interleukin (IL)-6 production by macrophages through Mitogen-Activated Protein Kinase (MAPK) and NF-κB signaling pathways[J]. Int J Mol Sci, 2014, 15(2): 2916-2928.
[15]Schulz C, Von Brühl ML, Barocke V, et al. EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall[J]. J Throm Haem, 2011, 9(5): 1007-1019.
[16]Meng F, Liu L, Chin PC, et al. Akt is a downstream target of NF-κB[J]. J Biol Chem, 2002, 277(33): 29674-29680.
[17]Kim KS, Lee DS, Bae GS, et al. The inhibition of JNK MAPK and NF-κB signaling by tenuifoliside A isolated from Polygala tenuifolia in lipopolysaccharide-induced macrophages is associated with its anti-inflammatory effect[J]. Euro J Pharmacol, 2013, 721(1): 267-276.
[18]Dixon DA, Tolley ND, Bemis-Standoli K, et al. Expression of COX-2 in platelet- monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling[J]. J Clin Invest, 2006, 116(10): 2727.
[19]Pettus BJ, Bielawski J, Porcelli AM, et al. The sphingosine kinase 1/sphingosine- 1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-α[J]. FASEB J, 2003, 17(11): 1411-1421. |